搜尋結果
A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly’s Q1
Forbes· 6 日前Eli Lilly stock (NYSE: LLY) will report its Q1 results on Tuesday, April 30. The pharmaceutical ...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 日前Eli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling ...
Bristol Myers Beats on Revenue as Revlimid Sales Decline Slows
Bloomberg· 7 日前Have a confidential tip for our reporters? The company will eliminate 2,200 jobs this ... ...
Walgreens’ Next Frontier: Complex Conditions & Cell And Gene Therapy
Forbes· 3 日前With the launch of this new initiative, Walgreens aims to focus on a</ ...
Here are 5 sectors of the market that are working and the stocks that stand out in each ...
CNBC· 3 日前Can it be put in a data center? Let's dispense with the macro before I get into what's ...
Mexican cement maker Cemex's Q1 profit climbs despite dip in volumes
Reuters· 7 日前on Thursday, bolstered by lower taxes and less exposure to financial derivatives, although its ...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 19 小時前Sales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition ... ...
Reactions: Biden administration plans to reclassify marijuana
Reuters· 1 日前The U.S. Justice Department on Tuesday moved to make marijuana use a</ ...
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's ...
CNBC· 2 日前The Federal Trade Commission on Tuesday said it is challenging hundreds of alleged ...
AI Supercharges Fentanyl Production And Distribution, Study Finds
Forbes· 5 日前The study’s implications suggest that if only a fraction of the ...